Lisinopril and Hydrochlorothiazide
- Product NDC
- 53002-1674
- 11-digit product format
- 530021674
- Labeler code
- 53002
- Product ID
- 53002-1674_f5bb51c1-0e3c-42d7-8a31-684d7d86d75c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-04-10
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1674-0 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
| 53002-1674-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1674 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [RPK PHARMACEUTICALS, INC.] | 3 | Legacy NDC, 2 package rows | 20230609_1b8ac4ae-8f0d-43a2-97b8-3c3c6a406d8d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1674-0 | 53002167400 | 100 TABLET in 1 BOTTLE (53002-1674-0) | 100 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-1674-3 | 53002167403 | 30 TABLET in 1 BOTTLE (53002-1674-3) | 30 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |